Er Breast Cancer clinical trials

Explore recruiting er breast cancer clinical trials.

Recruiting er breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Er Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC-1745-ETF-BCG: A Phase II study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS with high-risk ER+/HER2- early breast cancer (APPALACHES)

Spain, Germany, Portugal, Poland, Belgium, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer

France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Modular Open-Label, Multi-Centre Phase 1/2 Dose-Finding, Optimisation, and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0062 as monotherapy and in combination in Patients with Relapsed Locally Advanced or Metastatic AR+/HER2-/ER+ Breast Cancer

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Er Breast Cancer trials by city

Er Breast Cancer in Toronto Er Breast Cancer in Vancouver Er Breast Cancer in Montreal Er Breast Cancer in Calgary Er Breast Cancer in Edmonton Er Breast Cancer in Ottawa Er Breast Cancer in Winnipeg Er Breast Cancer in Quebec City Er Breast Cancer in Hamilton Er Breast Cancer in Kitchener Er Breast Cancer in London Er Breast Cancer in Halifax Er Breast Cancer in New York Er Breast Cancer in Los Angeles Er Breast Cancer in Chicago Er Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease